Clinical Trials Browser

Phase 1 × tivozanib × Thoracic × Clear all

NCT00826878 2012-06-28

An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung